Does informing people about their genetic risk of obesity help them change their habits and lose excess weight? A study published in the journal Obesity Reviews by scientists, including researchers from SWPS University, shows ...
Jul 13, 2026
0
1
For generations, early to bed and early to rise was seen as the blueprint for a healthy life, and any departure from it was often considered unhealthy. Scientists, however, have discovered that whether someone is an early ...
Phase 3 clinical trial results (TRANSCEND-T2D-1) published in The Lancet report that retatrutide, an investigational once-weekly injection for diabetes management, can significantly improve blood sugar levels and lead to ...
Jul 11, 2026
0
871
For many people living with obesity, newer weight-loss medicines such as Wegovy and Mounjaro have been transformative. These drugs are often grouped under the label GLP-1 medicines because they mimic hormones released after ...
Jul 10, 2026
0
6
The share of U.S. adults taking GLP-1 medications to lose weight has reached a record 11%.
Jul 9, 2026
0
14
Obesity and dietitian societies have joined forces to issue a new consensus statement on recommendations surrounding the use of obesity drugs for weight loss treatment. The statement, which is published in The Lancet Diabetes ...
Jul 9, 2026
0
5
A new therapy helps achieve a healthier BMI in people whose weight has become dysregulated following treatment for a brain tumor, a clinical trial has found. The results of the trial have been published in the New England ...
Jul 9, 2026
0
3
Medicare prescriptions for Wegovy increased sharply after the program started covering the anti-obesity medication to prevent heart problems, but just a fraction of beneficiaries likely eligible received the treatment, according ...
Jul 9, 2026
0
6
People with anorexia nervosa have unusually high levels of a hormone called LEAP2 in their blood when they are in the acute phase of the disorder, according to research presented at the Federation of European Neuroscience ...
Jul 9, 2026
0
4
Despite substantial weight loss, most obesity drugs such as Wegovy and Mounjaro do not meaningfully improve quality of life, and few show cardiovascular benefits at one year, according to an analysis of the latest evidence ...
Jul 8, 2026
0
66
